Recent progress of prognostic biomarkers and risk scoring systems ...

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia.

A better understanding of prognostic biomarkers, including serum markers, flow cytometry outcomes, IGHV mutation status, microRNAs, chromosome ...

Recent progress of prognostic biomarkers and risk scoring systems ...

PDF | Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia with high heterogeneity in the western world. Thus, investigators.

Recent progress of prognostic biomarkers and risk scoring systems ...

AbstractChronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia with high heterogeneity in the western world. Thus, investigators identified ...

Current advances in prognostic and diagnostic biomarkers for solid ...

The major concern in disease prognosis is the timely detection of resectable or metastatic tumour, thus reinforcing the need for identification of biomarkers ...

An overview of prognostic markers in patients with CLL - Frontiers

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia. biomark Res. (2020) 8. doi: 10.1186 ...

Predicting the outcome of patients with chronic lymphocytic ...

A prognostic biomarker is a biomarker that is informative for the likelihood of a given event (eg, disease progression) to occur in untreated ...

Tumor biomarkers for diagnosis, prognosis and targeted therapy

Besides classical biomarkers used in clinical practice, recent advances in molecular biology technologies have significantly improved the ...

[PDF] Development of a comprehensive prognostic index for ...

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia · X. YunYa ZhangXin Wang. Medicine. Biomarker research. 2020.

Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of ...

In this review, we discuss the prognostic role of these genomic markers in relation to novel treatments. Moreover, we present and discuss new scoring systems ...

An update on methods for detection of prognostic and predictive ...

While prognostic biomarkers indicate a patient's disease outcome regardless of treatment, predictive biomarkers are used to estimate how likely a patient will ...

Is it time for a reassessment of prognostic features in B-cell chronic ...

Prognostic assessment of B-cell chronic lymphocytic ... Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia.

Prognostic biomarkers in chronic lymphocytic leukemia

... in Fig. 3) On the base of these models, more risk scoring systems were reported to assist in risk stratification. The detailed information about prognostic ...

Molecular International Prognostic Scoring System ... - NEJM Evidence

Combining genomic profiling with hematologic and cytogenetic parameters, the IPSS-M improves the risk stratification of patients with MDS and ...

Prognostic Biomarker - an overview | ScienceDirect Topics

For prognostic biomarkers, in addition to independent validation, they must outperform existing conventional factors such as stage, age, performance status to ...

Chronic lymphocytic leukemia: A prognostic model comprising only ...

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia · X. YunYa ZhangXin Wang. Medicine. Biomarker research. 2020.

Prognostic factors in chronic lymphocytic leukemia

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia. Article Open access 07 September 2020. Use ...

Established and Novel Prognostic Biomarkers in Multiple Myeloma

Biomarkers could be diagnostic, in which their detection indicates the presence of disease, such as M protein in plasma cell dyscrasias, and subsequently can be ...

Genome-wide identification and analysis of prognostic features in ...

We identified more than 100,000 significant prognostic biomarkers and demonstrate that these genomic features can predict patient outcomes in clinically ...

Prognostic and predictive biomarker developments in multiple ...

However, despite new and improved biomarkers for determining the prognosis of patients, there is currently insufficient information to utilise ...